If you could vote on Brexit now which option would you choose?
   

Bayer aims to help CureVac with COVID-19 vaccine output, says CEO


German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive was quoted as saying on Sunday. Though inoculation campaigns have started around the world using various COVID-19 vaccines, many countries say their ability to get shots into arms is being limited by lower than expected supplies owing to a shortage of production. “We are prepared to pull out all the stops for this,” Werner Baumann told the Welt am Sonntag newspaper. “This is not primarily about financial considerations but about making the vaccine available as quickly as possible.” Bayer agreed this month to help fellow German company CureVac with development of its COVID-19 vaccine candidate, which is in late-stage clinical trials and has not yet been approved.

Reuters - January 17, 2021

View the full story here: https://www.reuters.com/article/us-health-coronavirus-curevac-bayer-idUKKBN29M09P?fbclid=IwAR3dvTpwXxMj6_C2HeZfd9cygaxm8LB6DCsydj6MGwVtV2YnbmQxgiV00jQ